A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.
A medical student shares how both storytelling and story-listening can be beneficial for physicians (and their patients).
A Stanford-designed computer algorithm helps doctors predict the lifespan of patients with metastatic cancer by looking for clues in their own exam notes.
In the fifth installment in the Understanding AFib series, Randall Stafford explains how to measure your heart rate and pay attention to your heart rhythm.
In this essay, Cynthia Lim reflects on her experience caring for her husband, who was left with brain damage following a cardiac arrest.
The first nursing postdoc at Stanford, Nancy Dudley, brings a passion for the care of the severely ill to her palliative care research.
Stanford’s Peter Koltai is participating in an effort to advance much-needed ENT care for children in Zimbabwe.
The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds
A stage IV cancer patient discusses what it means to live well with serious illness at Stanford Medicine's Jonathan King Lecture series.
In this fourth post in the Understanding AFib series, physician Randall Stafford explains different drugs that are used to slow down the heart.
When 12-year-old Lizneidy Serratos was airlifted to the Bay Area in early August, her heart was pumping so weakly that she could not walk or eat.
Patient advocate Elizabeth Jameson prints works of art from MRI scans of her own brain to foster dialogue about life with illness.
A Stanford Health Care video tells the story of grateful transplant patient Yolanda.
A new generation of brain cancer patients are working to improve care and connect and support patients using social media and advocacy.
In the latest installment in the series Understanding AFib, Randall Stafford explains the different types of blood thinners.
Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.
